Skip to content

Henry Schein HSIC Preferred Stock, Shares Outstanding

Preferred Stock, Shares Outstanding at other companies

Medline, Inc.
 logo
Medline, Inc. MDLN
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
IQVIA logo
IQVIAIQV

Other financials

Income statement

See full
Revenue$3.4B+6.3%
Gross profit$1.1B+7.0%
Operating income$182.0M+4.0%
Net income$107.0M-2.7%
EPS (diluted)$0.92+4.5%

Balance sheet

See full
Cash & equivalents$138.0M+8.7%
Total debt$3.7B+17.2%
Total equity$3.3B-1.3%
Total assets$11.3B+7.9%

Cash flow

See full
Operating cash flow-$97.0M-362%
CapEx$25.0M-19.4%
Free cash flow-$122.0M-2,133%

Valuation

See full
Market cap$9.1B-0.6%
Enterprise value$12.69B+4.2%
P/E23.1×+0.5×
P/S0.7×0.0×

Profitability

See full
Gross margin31.2%-0.4pp
Operating margin4.9%-0.2pp
Net margin3%-0.3pp
FCF margin3.3%-1.0pp

Returns & leverage

See full
Return on equity12%+0.2pp
Debt / equity1.1×+0.2×
Current ratio1.4×0.0×

Where this comes from

Reported directly by Henry Schein in its filing.

Tagged under the XBRL concept us-gaap:PreferredStockSharesOutstanding.

The official record: Henry Schein’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Henry Schein's preferred stock, shares outstanding.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Henry Schein's preferred stock, shares outstanding?
Henry Schein (HSIC) reported preferred stock, shares outstanding of $0 in Q1 2026.